12/17/2024
Glucagon-like peptide-1 (GLP-1) receptor agonists have quickly become an essential tool in managing type 2 diabetes. These drugs mimic the natural GLP-1 hormone by enhancing insulin secretion from the pancreas. In addition, their ability to improve glycemic control, promote weight loss, and provide cardiovascular benefits has increased their popularity among the general population. Available as daily and weekly formulations, these drugs present distinct pharmacological profiles that have implications for perioperative care, particularly concerning gastric emptying and glycemic management.
Glucagon-like peptide-1 (GLP-1) receptor agonists have quickly become an essential tool in managing type 2 diabetes.